Chronic disease increases the odds of hospitalization from heat exposure, study finds

FHS
May 8, 2024
9:00 am

The impact of ambient heat exposure on hospitalizations among individuals with varying numbers and combinations of chronic diseases.

GlycoMimetics’ AML drug flunks Phase 3 trial, quashing filing plans as stock sinks

GlycoMimetics’ stock $GLYC tanked over 60% in premarket trading Monday morning after the biotech announced a Phase 3 trial failure for its lead drug, uproleselan,

May 7, 2024

The impact of implementing a high sensitivity assay for cardiac troponin I on long term outcomes in patients with suspected acute coronary syndrome

Researchers from the United Kingdom evaluated the use of a high-sensitivity assay to measure cardiac troponin I and its impact on myocardial infarction (MI) risk

November 30, 2023

WHO declares mpox outbreak a global health emergency

The World Health Organization on Wednesday declared the spread of mpox in multiple African countries a public health emergency of international concern, the second such

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.